{'fraction_non_alphanumeric': 0.04411764705882353, 'fraction_numerical': 0.03609625668449198, 'mean_word_length': 5.747747747747748, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Auditory processing in AD: An EEG study

Alzheimer's disease is a progressive neurodegenerative disorder, which is associated with cognitive impairment, behavioral disorders and memory loss, among others (Andrade, Cortes, Guzman‐Martinez and Maccioni, 2017; Cortés, Andrade and Maccioni, 2018; Tarawneh and Holtzman, 2012). By 2050, nearly 14 million (13.8 million) Americans over age 65 could be living with the disease (Hebert, Weuve, Scherr and Evans, 2013), a fact that highlights the importance of identifying and discriminating biomarkers; the reason why the study is mainly conducted: to indicate whether or not auditory deficits occur in patients with Alzheimer's disease (AD) and memory deficits and hence to identify potential biomarkers.